Adenoma Detection Rate of Standard Colonoscopy Declines After Exposure to AI-Assisted Colonoscopy

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 13, 2025.

via HealthDay

WEDNESDAY, Aug. 13, 2025 -- Exposure to artificial intelligence (AI)-assisted colonoscopy is associated with a reduction in the adenoma detection rate (ADR) by endoscopists performing standard non-AI-assisted colonoscopy, according to a study published online Aug. 12 in The Lancet Gastroenterology & Hepatology.

Krzysztof Budzyń, M.D., from the Academy of Silesia in Katowice, Poland, and colleagues conducted a retrospective observational study at four endoscopy centers in Poland, which introduced AI tools for polyp detection at the end of 2021, after which colonoscopies were randomly assigned to be conducted with or without AI assistance according to the examination date. The change in ADR of standard non-AI-assisted colonoscopy before and after AI exposure was examined as the primary outcome.

A total of 1,443 patients underwent standard non-AI-assisted colonoscopy before and after AI introduction (795 and 648, respectively). The researchers observed a significant decrease in the ADR of standard non-AI-assisted colonoscopy from 28.4 percent before to 22.4 percent after exposure to AI. A multivariate analysis revealed that independent factors significantly associated with ADR included exposure to AI, male versus female patient sex, and patient age 60 years or older versus younger than 60 years (odds ratios, 0.69, 1.78, and 3.60, respectively).

"To our knowledge this is the first study to suggest a negative impact of regular AI use on health care professionals' ability to complete a patient-relevant task in medicine of any kind," coauthor Marcin Romańczyk, M.D., also from the Academy of Silesia, said in a statement. "Our results are concerning given the adoption of AI in medicine is rapidly spreading."

Several authors disclosed ties to the medical technology industry.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-14 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords